CNBX Pharmaceuticals Inc. (CNBX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

90.65M
Year ended 2025-08-31
n/m
3-year compound annual growth
138.52M2021-08-31: 138.52M2022-08-31: 1.22M2023-08-31: 8.82M2024-08-31: 30.25M2025-08-31: 90.65M90.65M
2021-08-31 Weighted Average Diluted Shares (shares) 2025-08-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-08-3190.65M+199.7%2025-12-01, From 2024-09-01
2024-08-3130.25M+242.8%2025-12-01, From 2023-09-01
2023-08-318.82M+621.8%2024-11-29, From 2022-09-01
2022-08-311.22M-99.1%2023-11-30, From 2021-09-01
2021-08-31138.52Mn/a2022-11-30, From 2020-09-01